Concepedia

Naoya Suehiro

NS

Statistics

Publications

3

Citations

50

H-Index

3

Active since

2019

Affiliations

Keio University(Current)

Hakodate Central General Hospital

Keio University Hospital

Naoya Suehiro is an author at Keio University specializing in pharmacology, therapeutic drug monitoring biomarkers, and cancer biomarkers.

Publications per year

2019–2023

3

Publications

3

Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study

Emi Ishikawa, Yuta Yokoyama, Haruna Chishima et al. · Investigational New Drugs · 2023 · 25 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Discovery of a New STAT3 Inhibitor Acting on the Linker Domain

Tatsuya Koseki, Naoya Suehiro, Yoshiaki Masuda et al. · Biological and Pharmaceutical Bulletin · 2019 · 13 citations · Full text

Life Sciences, Oncology, Pharmacology +15

Development and validation of a new liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of afatinib, dacomitinib, osimertinib, and the active metabolites of osimertinib in human serum

Emi Ishikawa, Yuta Yokoyama, Haruna Chishima et al. · Journal of Chromatography B · 2022 · 12 citations · Full text

Medicine, Oncology, Pharmacology +16

1–3 of 3